[1] |
Buchheit KM, Bernstein JA. Progestogen hypersensitivity: hetero⁃geneous manifestations with a common trigger[J]. J Allergy Clin Immunol Pract, 2017,5(3):566⁃574. doi: 10.1016/j.jaip.2017.01. 019. <br />
|
[2] |
Hughes GC. Progesterone and autoimmune disease[J]. Autoimmun Rev, 2012,11(6⁃7):A502⁃A514. doi: 10.1016/j.autrev.2011.12.003.<br />
|
[3] |
Tan IJ, Peeva E, Zandman⁃Goddard G. Hormonal modulation of the immune system a spotlight on the role of progestogens[J]. Autoimmun Rev, 2015,14(6):536⁃542. doi: 10.1016/j.autrev.2015. 02.004.<br />
|
[4] |
Snyder JL, Krishnaswamy G. Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: a case report and literature review[J]. Ann Allergy Asthma Immunol, 2003,90(5):469⁃477. doi: 10.1016/S1081⁃1206(10)61838⁃8. <br />
|
[5] |
Im S, Lee ES, Kim W, et al. Expression of progesterone receptor in human keratinocytes[J]. J Korean Med Sci, 2000,15(6):647⁃654. doi: 10.3346/jkms.2000.15.6.647. <br />
|
[6] |
Nguyen T, Razzaque AA. Autoimmune progesterone dermatitis: update and insights[J]. Autoimmun Rev, 2016,15(2):191⁃197. doi: 10.1016/j.autrev.2015.11.003. <br />
|
[7] |
Schoenmakers A, Vermorken A, Degreef H, et al. Corticosteroid or steroid allergy?[J]. Contact Dermatitis, 1992,26(3):159⁃162. <br />
|
[8] |
James T, Ghaferi J, LaFond A. The histopathologic features of autoimmune progesterone dermatitis[J]. J Cutan Pathol, 2017,44(1):70⁃74. doi: 10.1111/cup.12848. <br />
|
[9] |
Hill JL, Carr TF. Iatrogenic autoimmune progesterone dermatitis treated with a novel intramuscular progesterone desensitization protocol[J]. J Allergy Clin Immunol Pract, 2013,1(5):537⁃538. doi: 10.1016/j.jaip.2013.06.005. <br />
|
[10] |
Wojnarowska F, Greaves MW, Peachey RD, et al. Progesterone⁃induced erythema multiforme[J]. J R Soc Med, 1985,78(5):407⁃408. doi: 10.1177/014107688507800512. <br />
|
[11] |
Bourgeault E, Bujold J, Doucet ME. A rare case of oestrogen dermatitis[J]. J Cutan Med Surg, 2017,21(3):261⁃262. doi: 10. 1177/1203475416685075. <br />
|
[12] |
Bernstein IL, Bernstein DI, Lummus ZL, et al. A case of progesterone⁃induced anaphylaxis, cyclic urticaria/angioedema, and autoimmune dermatitis[J]. J Womens Health (Larchmt), 2011,20(4):643⁃648. doi: 10.1089/jwh.2010.2468. <br />
|
[13] |
Benagiano G, Bastianelli C, Farris M. Hormonal contraception: present and future[J]. Drugs Today (Barc), 2008,44(12):905⁃923. doi: 10.1358/dot.2008.44.12.1299292. <br />
|
[14] |
Bhavnani BR, Stanczyk FZ. Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action[J]. J Steroid Biochem Mol Biol, 2014,142:16⁃29. doi: 10.1016/j.jsbmb.2013.10. 011. <br />
|
[15] |
Domeyer⁃Klenske A, Robillard D, Pulvino J, et al. Gonadotropin⁃releasing hormone agonist use to guide diagnosis and treatment of autoimmune progesterone dermatitis[J]. Obstet Gynecol, 2015,125(5):1114⁃1116. doi: 10.1097/AOG.0000000000000569. <br />
|
[16] |
Cosman F. Selective estrogen⁃receptor modulators[J]. Clin Geriatr Med, 2003,19(2):371⁃379.<br />
|
[17] |
Foer D, Buchheit KM. Progestogen hypersensitivity: an evidence⁃based approach to diagnosis and management in clinical practice[J]. Immunol Allergy Clin North Am, 2017,37(4):773⁃784. doi: 10.1016/j.iac.2017.07.006. <br />
|
[18] |
Drayer SM, Laufer LR, Farrell ME. Autoimmune progesterone dermatitis presenting as Stevens⁃Johnson syndrome[J]. Obstet Gynecol, 2017,130(4):881⁃884. doi: 10.1097/AOG.000000000000 2256. <br />
|
[19] |
Foer D, Buchheit KM, Gargiulo AR, et al. Progestogen hypersensi⁃tivity in 24 cases: diagnosis, management, and proposed renaming and classification[J]. J Allergy Clin Immunol Pract, 2016,4(4):723⁃729. doi: 10.1016/j.jaip.2016.03.003.<br />
|